NCT07148349

Brief Summary

This is a retrospective cohort study utilizing radiographic and computed tomography (CT) imaging data collected during routine clinical care at Schulthess Klinik Zürich. The study focuses on developing and validating artificial intelligence (AI)-based tools for the assessment of trapeziometacarpal (TMC) joint osteoarthritis (OA) and implant monitoring. The project is divided into four subprojects: (1) development of a new radiographic classification system for TMC OA, (2) automation of the classification using deep learning, (3) automated detection of implant migration, and (4) 3-dimensional (3D) reconstruction of the TMC joint from biplanar radiographs. Data will be sourced from two cohorts: patients from our clinical TMC arthroplasty registry who received the Touch implant, and patients with other wrist-related conditions who underwent radiographic imaging with a visible TMC joint. Together, these cohorts provide a broad coverage across the full spectrum of OA severity. OA-related features and implant related features will serve as the foundation for model training and validation. Also, they will be validated with CT images regarding reliability and accuracy. The resulting prototypes for automated OA staging, implant migration detection, and 3D modeling of the TMC joint are exclusively used for research purposes. Any future clinical use of these tools, including evaluation under Swissmedic (Swiss Agency for Therapeutic Products) regulations, will be part of a separate project.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,500

participants targeted

Target at P75+ for all trials

Timeline
28mo left

Started Sep 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Sep 2025Aug 2028

First Submitted

Initial submission to the registry

August 21, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 29, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

2.9 years

First QC Date

August 21, 2025

Last Update Submit

April 29, 2026

Conditions

Keywords

Thumb Saddle JointOsteoarthritisArtificial IntelligenceCarpometacarpalTrapeziometacarpalCMC ITMC3D ReconstructionImplant migrationComputer Vision

Outcome Measures

Primary Outcomes (4)

  • New TMC OA classification

    Create a novel classification system for TMC OA based on joint and bone features in X-rays. This system should ensure better reliability, accurately reflect joint health, and provide clinically relevant insights for treatment decisions.

    Preoperative

  • Automation of the new TMC OA classification

    Implement a deep learning-based system to automate TMC joint OA classification in plain radiographs using convolutional neural networks for segmentation and feature extraction. This approach aims to improve consistency and reduce the need for manual annotations.

    Preoperative

  • Automated implant migration detection

    Develop an AI-based system for detecting implant loosening and migration in postoperative radiographs, for early detection of loosening and long-term monitoring of implant stability.

    Postoperative

  • 3D reconstruction of the TMC joint

    Create a 3D reconstruction of the trapezium and the first metacarpal from biplanar radiographs. This provides advanced insights into individual trapezium geometry to improve surgical planning.

    Preoperative

Study Arms (2)

Osteoarthritis

Patients in our TMC arthroplasty registry (Business Administration System for Ethics Committees (BASEC) number: 2019-02096): Patients who received a Touch implant for TMC joint arthroplasty. Data will be included in the study from the creation of the registry in 2018 until the end of January 2028.

Other: No Intervention: Observational Cohort

Healthy

Patients with other clinical conditions leading to TMC joint radiography.

Other: No Intervention: Observational Cohort

Interventions

No Intervention: Observational Cohort

HealthyOsteoarthritis

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of patients treated at Schulthess Klinik Zürich with available radiographic imaging of the TMC joint. Data are derived from two cohorts: (1) patients enrolled in the TMC arthroplasty registry (BASEC number: 2019-02096) who received a Touch implant since 2018, and (2) patients with other wrist-related conditions requiring radiographs in which the TMC joint is clearly visible. The combined cohorts provide a balanced representation across the spectrum of TMC joint OA severity, from healthy joints to end-stage disease.

You may qualify if:

  • Patients will be included in the study if they have provided written general consent for the use of their clinical data and meet the requirements of one of the following two groups:
  • TMC OA group:
  • Patients who received a Touch implant for TMC joint arthroplasty and are documented in our clinical registry
  • Other clinical conditions:
  • Patients who underwent radiographic imaging for one of the following conditions, with a clearly visible TMC joint, for example: Distal radius fracture, carpal fracture, finger dislocation, or similar.

You may not qualify if:

  • TMC OA group:
  • Patients with posttraumatic OA.
  • Patients with rheumatoid arthritis.
  • Other clinical conditions:
  • Eaton Littler score higher than one.
  • Prior surgery affecting the trapezium or the first metacarpal.
  • Clinical condition resulting in abnormal TMC joint morphology.
  • Furthermore, patients will also be excluded if they revoke their consent in writing or via verbal withdrawal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schulthess Klinik

Zurich, Canton of Zurich, 8008, Switzerland

Location

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2025

First Posted

August 29, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

August 1, 2028

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

IPD will not be shared. The study involves sensitive clinical data that is subject to privacy protections and institutional regulations. Ownership of the data remains with the clinic, and confidentiality requirements prevent making these data publicly available.

Locations